Eli Lilly beats earnings, lifts outlook on booming Zepbound and Mounjaro sales
Eli Lilly reported stronger-than-expected fourth-quarter earnings and issued robust guidance for the coming year, as soaring demand for its GLP-1 drugs reaffirmed its
Eli Lilly reported stronger-than-expected fourth-quarter earnings and issued robust guidance for the coming year, as soaring demand for its GLP-1 drugs reaffirmed its
Eli Lilly reported stronger-than-expected fourth-quarter earnings and issued robust guidance for the coming year, as soaring demand for its GLP-1 drugs reaffirmed its
Eli Lilly reported stronger-than-expected fourth-quarter earnings and issued robust guidance for the coming year, as soaring demand for its GLP-1 drugs reaffirmed its
Solana faces strong selling pressure and is trading near $103. U.S.-listed spot Solana ETFs saw $5.58M inflows amid market weakness. The majority of
US stock index futures were muted on Wednesday after a sharp rotation out of technology stocks dragged major benchmarks to a losing session,
US stock index futures were muted on Wednesday after a sharp rotation out of technology stocks dragged major benchmarks to a losing session,
Polygon’s POL is one of the best performers among the top 100 cryptocurrencies by market cap. The coin takes a breather above $0.11
Polygon’s POL is one of the best performers among the top 100 cryptocurrencies by market cap. The coin takes a breather above $0.11
Polygon’s POL is one of the best performers among the top 100 cryptocurrencies by market cap. The coin takes a breather above $0.11
Chainlink fell below the $10 level as selling pressure continued, with price down over 20% on the weekly chart. Technical indicators show LINK